Gamal A. E. Mostafa

Validated liquid chromatographic-fluorescence method for the quantitation of gemifloxacin in human plasma

A highly selective, sensitive and rapid high performance liquid chromatographic method has been developed and validated to quantify gemifloxacin in human plasma. The gemifloxacin and internal standard (ciprofloxacin) were extracted by ultrafiltration technique followed by injection into chromatographic system. Chromatographic separation was achieved on a reversed phase C(18) column with a mobile phase of acetonitrile:0.1% trifluoroacetic acid (20:80, v/v) using isocratic elution (at flow rate 1 mL min(-1)). The analytes were detected at 269 and 393 nm for excitation and emission, respectively. The assay exhibited a linear range of 25-5000 ng mL(-1) for gemifloxacin in human plasma. The lower limit of detection was 10 ng mL(-1). The method was statistically validated for linearity, accuracy, precision and selectivity following FDA guidelines. The intra- and inter-assay coefficients of variation did not exceed 7.6% deviation of the nominal concentration. The recovery of gemifloxacin from plasma was greater than 97.0%. Stability of gemifloxacin in plasma was excellent with no evidence of degradation during sample processing (auto-sampler) and at least 3 months storage in a freezer at -70 °C. This validation method is applied for clinical study of the gemifloxacin in human volunteers.

Characteristics of new composite-and classical potentiometric sensors for the determination of pioglitazone in some pharmaceutical formulations

The construction and electrochemical response characteristics of poly(vinyl chloride) membrane sensors for pioglitazone HCl (PG) are described. The sensing membranes incorporate ion association complexes of pioglitazone cation and sodium tetraphenylborate (NaTPB) (sensor 1) or phosphomolybdic acid (PMA) (sensor 2) or phosphotungstic acid (PTA) (sensor 3) as electroactive materials. The sensors display a fast, stable and near-Nernstian response over a relative wide pioglitazone concentration range (1x10(-2) to 10(-6) M), with cationic slopes of 55.0+/-0.5, 58.0+/-0.5 and 53.0+/-0.5 mV per concentration decade over a pH range of 1.0-5.0. The sensors show good discrimination of pioglitazone from several inorganic and organic compounds. The direct determination of 2.5-3900.0 microg/ml of pioglitazone show an average recovery of 98.5, 99.0 and 98.4% and a mean relative standard deviation of 1.6, 1.5 and 1.7% at 100.0 microg/ml for sensors 1, 2 and 3, respectively. The proposed sensors have been applied for direct determination of pioglitazone in some pharmaceutical preparations. The results obtained by determination of pioglitazone in tablets using the proposed sensors are comparable favorably with those obtained using the HPLC method. The sensors have been used as indicator electrodes for potentiometric titration of pioglitazone.

High-performance liquid chromatographic method for the determination of dasatinib in rabbit plasma using fluorescence detection and its application to a pharmacokinetic study.

A highly selective, sensitive, and rapid high performance liquid chromatographic (HPLC) method has been developed and validated to quantify dasatinib, a tyrosine kinase inhibitor, in rabbit plasma. Montelukast was used as internal standard (IS). Dasatinib and IS were extracted by deproteinization technique, followed by injection of aliquot of supernatant into chromatographic system. Chromatographic separation was achieved on a reversed phase C18 column with a mobile phase of 0.02M potassium dihydrogen phosphate:methanol (10:90, v/v) pumped at flow rate of 2.0mL/min. The analytes were detected at 340 and 374nm for excitation and emission, respectively. The assay exhibited a linear range of 50.0-3000ng/mL, with a lower detection limit of 15.0ng/mL. The method was statistically validated for linearity, accuracy, precision, selectivity and stability following FDA guidelines. The intra- and inter-assay coefficients of variation did not exceed 13.5% from the nominal concentration. The accuracy of dasatinib was within ±15% of the theoretical value. The assay has been applied successfully in a pharmacokinetic study.

HPLC-fluorescence method for the enantioselective analysis of propranolol in rat serum using immobilized polysaccharide-based chiral stationary phase.

A stereoselective high-performance liquid chromatographic (HPLC) method was developed and validated to determine S-(-)- and R-(+)-propranolol in rat serum. Enantiomeric resolution was achieved on cellulose tris(3,5-dimethylphenylcarbamate) immobilized onto spherical porous silica chiral stationary phase (CSP) known as Chiralpak IB. A simple analytical method was validated using a mobile phase consisted of n-hexane-ethanol-triethylamine (95:5:0.4%, v/v/v) at a flow rate of 0.6 mL min(-1) and fluorescence detection set at excitation/emission wavelengths 290/375 nm. The calibration curves were linear over the range of 10-400 ng mL(-1) (R = 0.999) for each enantiomer with a detection limit of 3 ng mL(-1). The proposed method was validated in compliance with ICH guidelines in terms of linearity, accuracy, precision, limits of detection and quantitation, and other aspects of analytical validation. Actual quantification could be made for propranolol isomers in serum obtained from rats that had been intraperitoneally (i.p.) administered a single dose of the drug. The proposed method established in this study is simple and sensitive enough to be adopted in the fields of clinical and forensic toxicology. Molecular modeling studies including energy minimization and docking studies were first performed to illustrate the mechanism by which the active enantiomer binds to the β-adrenergic receptor and second to find a suitable interpretation of how both enantiomers are interacting with cellulose tris(3,5-dimethylphenylcarbamate) CSP during the process of resolution. The latter interaction was demonstrated by calculating the binding affinities and interaction distances between propranolol enantiomers and chiral selector.

Potentiometric determination of moxifloxacin in some pharmaceutical formulation using PVC membrane sensors

BackgroundThe construction and electrochemical response characteristics of Poly (vinyl chloride) membrane sensors for moxifloxacin HCl (MOX) are described. The sensing membranes incorporate ion association complexes of moxifloxacin cation and sodium tetraphenyl borate (NaTPB) (sensor 1), phosphomolybdic acid (PMA) (sensor 2) or phosphotungstic acid (PTA) (sensor 3) as electroactive materials.ResultsThe sensors display a fast, stable and near-Nernstian response over a relative wide moxifloxacin concentration range (1 × 10-2 - 4.0 × 10-6, 1 × 10-2 - 5.0 × 10-6, 1 × 10-2 - 5.0 × 10-6 M), with detection limits of 3 × 10-6, 4 × 10-6 and 4.0 × 10-6 M for sensor 1, 2 and 3, respectively over a pH range of 6.0 - 9.0. The sensors show good discrimination of moxifloxacin from several inorganic and organic compounds. The direct determination of 400 μg/ml of moxifloxacin show an average recovery of 98.5, 99.1 and 98.6% and a mean relative standard deviation of 1.8, 1.6 and 1.8% for sensors 1, 2 and 3 respectively.ConclusionsThe proposed sensors have been applied for direct determination of moxifloxacin in some pharmaceutical preparations. The results obtained by determination of moxifloxacin in tablets using the proposed sensors are comparable favorably with those obtained using the US Pharmacopeia method. The sensors have been used as indicator electrodes for potentiometric titration of moxifloxacin.

PVC Membrane Sensors for Potentiometric Determination of Acebutolol

The construction and general performance characteristics of two novel potentiometric membrane sensors responsive to the acebutolol are described. The sensors are based on the use of ion-association complexes of acebutolol (AC) with tetraphenylborate(TPB) (I) and phosphomolybdate(PM) (II) as exchange sites in a PVC matrix. The sensors show a fast, stable and near- Nernstian for the mono charge cation of AC over the concentration range 1×10-3 - ∼10-6 M at 25 °C over the pH range 2.0 - 6.0 with cationic slope of 51.5 ± 0.5 and 53.0 ± 0.5 per concentration decade for AC-I and AC-II sensors respectively. The lower detection limit is 6×10-6 M and 4×0-6 M with the response time 20-30 s in the same order of both sensors. Selectivity coefficients of AC related to a number of interfering cation and some organic compounds were investigated. There are negligible interferences are caused by most of the investigated species. The direct determination of 3 - 370 μg/ml of AC shows an average recovery of 99.4 and 99.5% and a mean relative standard deviation of 1.5% at 100.0 μg/ml for sensor I and II respectively. The results obtained by determination of AC in tablets using the proposed sensors which comparable favorably with those obtained by the British pharmacopoeia method. In the present investigation the electrodes have been utilized as end point indicator for some precipitation titration reactions.

Determination of donepezil hydrochloride in human plasma and pharmaceutical formulations by HPLC with fluorescence detection.

Determination of donepezil hydrochloride in human plasma and pharmaceutical formulations by HPLC with fluorescence detection A sensitive, isocratic reversed-phase high performance liquid chromatographic method involving fluorescence detection was developed for the determination of donepezil hydrochloride in tablets and in human plasma. Pindolol was used as an internal standard. Good chromatographic separation was achieved by using an analytical column C18. The system operated at room temperature using a mobile phase consisting of methanol, phosphate buffer (0.02 mol L-1) and triethyl amine (pH 3.5) (55: 45: 0.5, V/V/V) at a flow rate 0.9 mL-1 min. The analyte and internal standard were extracted from human plasma via liquid-liquid extraction. The proposed method was validated for sensitivity, selectivity, linearity, accuracy and precision. The calibration curve was linear over the range of 5-2000 ng mL-1 of donepezil with detection limit of 1.5 ng mL-1. Intra- and inter-day relative standard deviations were less than 2.5 %. The method was found to be suitable for quality control of donepezil hydrochloride in bulk drug as well as in human plasma. Određivanje donepezil hidroklorida u humanoj plazmi i ljekovitim oblicima pomoću HPLC s detekcijom fluorescencije Ovaj rad opisuje HPLC metodu određivanja donepezil hidroklorida (DP) u tabletama i u ljudskoj plazmi u nano području. Postavljena je osjetljiva metoda izokratične HPLC s fluorescencijskom detekcijom. Kao unutarnji standard upotrebljen je pindolol. Dobro kromatografsko odjeljivanje postignuto je primjenom analitičke kolone C18. Radna temperatura bila je sobna, a kao mobilna faza upotrebljena je smjesa metanola, fosfatnog pufera (0,02 mol L-1) i trietilamina (pH 3,5) (55: 45: 0.5, V/V/V). Analit i unutarnji standard su ekstrahirani iz ljudske plazme ekstrakcijom tekuće-tekuće. Predložena metoda je validirana s obzirom na selektivnost, područje linearnosti, ispravnost i preciznost. Kalibracijska funkcija bila je linearna u području od 5-2000 ng mL-1 donepezila, a granica detekcije iznosila je 2 ng mL-1. Relativna standardna devijacija za repetabilnost i intermedijarnu preciznost bila je manja od 2,5 %. Metoda je primjenljliva u kontroli kvalitete ljekovitih formulacija s DP-om i u praćenju DP-a u ljudskoj plazmi.

PVC matrix membrane sensor for potentiometric determination of dodecylsulfate

The construction and performance characteristics of a new potentiometric PVC membrane sensor for the determination of sodium dodecyl sulfate (SDS) are described. The sensor was based on the use of an N-cetyl-N,N,N trimethyl ammonium (CTA) dodecyl sulfate (DS) ion pair as ion exchange sites in PVC matrix in the presence of o-nitrophenyl octylether as plasticiser. The sensor exhibited a fast, stable, and near-Nernstian response for SDS over the concentration range of 1 × 10−3 to 10−6 M at 25°C and the pH range 4–8.5 with anionic slope of 52.5 ± 0.5 mV decade−1. The lower detection limit was 3 × 10−6 M, and the response time was 25 s. Selectivity coefficients of SDS with respect to a number of different species were investigated. There were negligible interferences caused by most of the investigated anions. The determination of 1.0–280.0 µg mL−1 of SDS in aqueous solutions showed an average recovery of 99.1%, and the mean relative standard deviation was 1.4 at 100 µg mL−1. The results obtained in the determination of SDS in liquid soap, water and in some pharmaceutical preparations compared favourably with those obtained by the Methylene Blue active substance method (MBAS). In the present investigation, the DS sensor has been used as an end-point indicator electrode for some precipitation titration reactions, e.g. titration of SDS with CTMABr and cetylpyridinium chloride with SDS.

Stereoselective HPLC analysis of tertatolol in rat plasma using macrocyclic antibiotic chiral stationary phase

Enantiomeric resolution of teratolol was achieved on a vancomycin macrocyclic antibiotic chiral stationary phase known as Chirobiotic V with UV detection set at 220 nm. The polar ionic mobile phase (PIM) consisted of methanol-glacial acetic acid-triethylamine (100:0.01:0.015, v/v/v) has been used at a flow rate of 0.8 ml min(-1) . The calibration curves in plasma were linear over the range of 5-500 ng ml(-1) for each enantiomer with detection limit of 2 ng ml(-1) . The proposed method was validated in compliance with the international conference on harmonization (ICH) guidelines. The developed method applied for the trace analyses of tertatolol enantiomers in plasma and for the pharmacokinetic study of tertatolol enantiomers in rat plasma. The assay proved to be suitable for therapeutic drug monitoring and chiral quality control for tertatolol formulations by HPLC.

An isocratic liquid chromatography-electrospray ionization tandem mass spectrometric determination of varenicline in human plasma and dosage form

A simple, sensitive and accurate liquid chromatography tandem mass spectrometric (LC/MS/MS) method has been developed and validated for determination of varenicline (VRC) in human plasma and pharmaceutical tablets as a tool for therapeutic drug monitoring. The VRC and internal standard (paracetamol, IS) were extracted by liquid-liquid extraction technique. The separation was achieved on C18 column (150mm × 4.6 mm, 5 µm, maintained at 25°C) by isocratic mode at a flow rate of 0.7 ml/min using a mobile phase consisted of a mixture of 5 mM ammonium formate, pH 7.5 (A) and (acetonitrile: methanol, 50:50, v/v) (B) in a ratio of A:B (15:85, v/v) for 10 min. The analytes were monitored by electrospray ionization in positive ion multiple reaction monitoring (MRM) mode. Optimization of MRM mode and chromatogrphic conditions were applied to elmeinate the interference peaks and increse of sensitivity. The method was linear ( r 2 = 0.9998) at concentration range of 20.0 to 500.0 ng/ml with lower limit of detection of 6.0 ng/ml. The method was statistically validated for linearity, accuracy, precision and selectivity following Food and Drug Administration (FDA) guidelines. The mean extraction recovery of VRC from human plasma was 87.06 ± 2.47%. The reproducibility of the method was reliable with the intra- and inter-day precision was < 5% and average accuracy of 103.54%. The validated method was successfully applied to quantify VRC in human plasma as well as bulk and dosage form in quality control laboratory.